Onderneming Oramed Pharmaceuticals Inc. Deutsche Boerse AG
Aandelen
OJU1
US68403P2039
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,234 EUR | +0,72% | +1,11% | +4,54% |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Solutions
100,0
%
| 3 | 100,0 % | 1 | 100,0 % | -50,43% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Israel
100,0
%
| 3 | 100,0 % | 1 | 100,0 % | -50,43% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 12-04-02 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12-04-02 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 14-04-13 |
Leonard Sank
BRD | Director/Board Member | 59 | 23-10-07 |
Zach Herschfus
IRC | Investor Relations Contact | - | - |
Netanel Derovan
LAW | General Counsel | - | 09-01-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12-04-02 |
Miriam Kidron
FOU | Founder | 83 | 12-04-02 |
Leonard Sank
BRD | Director/Board Member | 59 | 23-10-07 |
Arie Mayer
BRD | Director/Board Member | 67 | 05-12-19 |
Benjamin Shapiro
BRD | Director/Board Member | 40 | 01-05-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 40 519 160 | 35 939 036 ( 88,70 %) | 0 | 88,70 % |
Bedrijfsgegevens
Oramed Pharmaceuticals, Inc.
1185 Avenue of the Americas 3rd Floor
10036, New York
+844 967 2633
http://www.oramed.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,67% | 47,02 mld. | |
+49,39% | 41,86 mld. | |
+0,07% | 41,76 mld. | |
-4,27% | 28,8 mld. | |
+12,32% | 26,05 mld. | |
-21,63% | 19,15 mld. | |
+4,20% | 12,55 mld. | |
+29,51% | 12,34 mld. | |
-4,27% | 11,82 mld. |
- Beurs
- Aandelen
- Koers ORMP
- Koers OJU1
- Onderneming Oramed Pharmaceuticals Inc.